Engineering of a trispecific tumor-targeted immunotherapy incorporating 4-1BB co-stimulation and PD-L1 blockade
Warmuth, Stefan, Gunde, Tea, Snell, Daniel, Brock, Matthias, Weinert, Christopher, Simonin, Alexandre, Hess, Christian, Tietz, Julia, Johansson, Maria, Spiga, Fabio Mario, Heiz, Robin, Flückiger, Naomi, Wagen, Sandro, Zeberer, Julia, Diem, Dania, Mahler, Dana, Wickihalder, Belinda, Muntwiler, Simone, Chatterjee, Bithi, Küttner, Benjamin, Bommer, Bettina, Yaman, Yasemin, Lichtlen, Peter, Urech, David
Published in Oncoimmunology (01.01.2021)
Published in Oncoimmunology (01.01.2021)
Get full text
Journal Article
844 A trispecific ROR1 x CD3 T cell engager mediates in vitro tumor cell killing and in vivo tumor eradication
Chatterjee, Bithi, Snell, Daniel, Hess, Christian, Brock, Matthias, Spiga, Fabio, Simonin, Alexandre, Gunde, Tea, Warmuth, Stefan, Weinert, Christopher, Bassler, Nicole, Kirk, Niels, Schumacher, Nina, Mahler, Dana, Yaman, Yasemin, Bommer, Bettina, Gambino, Giorgio, Giezendanner, Noreen, Kuettner, Benjamin, Flueckiger, Naomi, Heiz, Robin, Wagen, Sandro, Diem, Dania, Zeberer, Julia, Urech, David
Published in Journal for immunotherapy of cancer (01.11.2021)
Published in Journal for immunotherapy of cancer (01.11.2021)
Get full text
Journal Article
Abstract 2871: NM28-2746, a reduced affinity bivalent mesothelin-binding MATCH4 T cell engager, with half-life extension, increases selectivity for killing of mesothelin-overexpressing cells
Chatterjee, Bithi, Hess, Christian, Snell, Daniel, Gunde, Tea, Warmuth, Stefan, Simonin, Alexandre, Brock, Matthias, Spiga, Fabio, Johansson, Maria, Weinert, Christopher, Tietz, Julia, Kirk, Niels, Bassler, Nicole, Mahler, Dana, Diem, Dania, Carrella, Alessandra, Giezendanner, Noreen, Alberti, Alessandra, Gambino, Giorgio, Wickihalder, Belinda, Bommer, Bettina, Muntwiler, Simone, Yaman, Yasemin, Flueckiger, Naomi, Heiz, Robin, Wagen, Sandro, Urech, David
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article